Key result
Genetically predicted higher HDL-C levels were strongly associated with an increased risk of early age-related macular degeneration (OR 1.25).
Why the study?
Age-related macular degeneration is a major cause of vision loss, but the causal effects of lipid biomarkers on early AMD remain unclear.
Do genetically predicted serum lipid biomarkers affect the risk of early age-related macular degeneration in individuals of European ancestry?
Observational (n=105,248)
Yes
Do genetically predicted serum lipid biomarkers affect the risk of early age-related macular degeneration in individuals of European ancestry?
Odds Ratio: 1.25 (95% CI 1.15–1.35)
p-value: p=2.61 × 10-8
Genetically elevated HDL-C and ApoA levels increase the risk of early AMD, whereas LDL-C, ApoB, and triglycerides decrease the risk, highlighting the complex role of lipid metabolism in early AMD development.
Higher HDL-C/ApoA may raise early AMD risk; hypothesis-generating for lipid modulation and needs prospective validation.
Background Age-related macular degeneration (AMD) is one of the major causes of vision loss. Early AMD needs to be taken seriously, whereas lipid biomarkers’ casual effects on early AMD remain unclear. Methods In this study, a two-sample Mendelian randomization (MR) analysis was performed to systematically assess the causal relationships between seven serum lipid biomarkers, consisting of apolipoprotein A (ApoA), apolipoprotein B (ApoB), total cholesterol (CHOL), high-density lipoprotein cholesterol (HDL-C), direct low-density lipoprotein cholesterol (LDL-C), lipoprotein A [Lp(a)], and triglycerides (TG), and the risk of early AMD. Totally, 14,034 cases and 91,214 controls of European ancestry were included in the analysis (Number of SNPs = 11,304,110). Results MR estimates showed that a higher HDL-C level was strongly associated with increased risk of early AMD (OR = 1.25, 95% CI: 1.15-1.35, P = 2.61 × 10 −8 ). In addition, the level of ApoA was also positively associated with the risk of early AMD (OR = 2.04, 95% CI: 1.50-2.77, P = 6.27 × 10 −6 ). Conversely, higher LDL-C levels significantly decreased the risk of early AMD (OR = 0.90, 95% CI: 0.85-0.96, P = 2.03 × 10 −3 ). In addition to LDL-C, higher levels of ApoB and TG were found to be positively associated with early AMD risk. Sensitivity analyses further supported these associations. Moreover, multivariable MR analyses, adjusting for the effects of correlated lipid biomarkers yielded similar results. Conclusion This study addresses the question of causality relationships that elevated circulating HDL-C/ApoA levels and increased risk of early AMD, whereas LDL-C, ApoB, and TG specifically reduce the risk of early AMD. These findings contribute to our better understanding of the role of lipid metabolism in drusen formation, particularly in early AMD development.
No takes yet. Share an insight, caveat, or question.
Li et al. (2021) conducted an observational in Early age-related macular degeneration (n=105,248). Genetically predicted higher HDL-C levels vs. Genetically predicted lower HDL-C levels was evaluated on Risk of early age-related macular degeneration (OR 1.25, 95% CI 1.15-1.35, p=2.61 × 10-8). Genetically predicted higher HDL-C levels were strongly associated with an increased risk of early age-related macular degeneration (OR 1.25).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: